GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · IEX Real-Time Price · USD
3.310
+0.030 (0.91%)
At close: Jul 2, 2024, 4:00 PM
3.220
-0.090 (-2.72%)
After-hours: Jul 2, 2024, 7:59 PM EDT

GeoVax Labs Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
8.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 202281.53K-303.98K-78.85%
Dec 31, 2021385.50K-1.44M-78.86%
Dec 31, 20201.82M647.76K55.09%
Dec 31, 20191.18M212.69K22.08%
Dec 31, 2018963.20K-112.07K-10.42%
Dec 31, 20171.08M246.35K29.72%
Dec 31, 2016828.92K400.84K93.64%
Dec 31, 2015428.08K-454.88K-51.52%
Dec 31, 2014882.96K-1.53M-63.48%
Dec 31, 20132.42M-239.78K-9.02%
Dec 31, 20122.66M-2.24M-45.77%
Dec 31, 20114.90M-285.37K-5.50%
Dec 31, 20105.19M1.52M41.36%
Dec 31, 20093.67M758.03K26.05%
Dec 31, 20082.91M2.67M1,127.90%
Dec 31, 2007237.00K-615.90K-72.21%
Dec 31, 2006852.91K182.44K27.21%
Dec 31, 2005670.47K-44.39K-6.21%
Dec 31, 2004714.85K--
Dec 31, 20030--
Dec 31, 20012.62M1.76M204.73%
Dec 31, 2000859.84K-1.42M-62.27%
Dec 31, 19992.28M-3.09M-57.54%
Dec 31, 19985.37M2.64M96.61%
Dec 31, 19972.73M--
Dec 31, 19962.73M2.64M2,805.93%
Dec 31, 199593.95K-9.51M-99.02%
Dec 31, 19949.60M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 31.76M
Sunshine Biopharma 26.74M
Precipio 15.81M
Plus Therapeutics 6.08M
PAVmed 3.02M
Fresh2 Group 2.35M
Inhibikase Therapeutics 195.98K
Bionomics 15.00K
Revenue Rankings